Abstract
Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. The main objectives of this review are to assess the diagnostic accuracy of first- and second-trimester fetal anomaly screening in low-risk pregnant women, and to compare overall performance of single- and two-stage screening approaches with regards to the number of cases detected before birth, as well as the proportion of false positive diagnoses. Secondary objectives Our secondary objective is to identify potential sources of heterogeneity between studies by investigating the effect of clinical factors (i.e. prior testing, factors related to the conduct of the ultrasound examination, and healthcare setting of the study) and methodological factors (i.e. related to the study design, such as methods used for postnatal ascertainment of cases) on screening performance.
Original language | English |
---|---|
Article number | CD014715 |
Journal | Cochrane Database of Systematic Reviews |
Volume | 2021 |
Issue number | 7 |
DOIs | |
Publication status | Published - 21 Jul 2021 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cochrane Database of Systematic Reviews, Vol. 2021, No. 7, CD014715, 21.07.2021.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations
AU - Buijtendijk, Marieke
AU - Shah, Harsha
AU - Lugthart, Malou A.
AU - Dawood, Yousif
AU - Limpens, Jacqueline
AU - de Bakker, Bernadette S.
AU - van den Hoff, Maurice J.B.
AU - Leeflang, Mariska M.G.
AU - Pajkrt, Eva
N1 - Funding Information: Marieke Buijtendijk receives funding from a Dutch Top Sector Life Sciences & Health Consortium grant to investigate visualisation of fetal anatomical structures by three-dimensional (3D) ultrasonography. Samsung Medison South Korea supports the research in three-dimensional ultrasonography through the loan of ultrasound equipment and partial coverage of the salary costs for the first year of the project (1 April 2019 to 1 April 2020). She received payment from NeuroLogica Corporation to present in a webinar on first trimester 3D ultrasoundimaging. Funding Information: This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Evidence Synthesis Programme, the NIHR, National Health Service (NHS) or the Department of Health and Social Care. Funding Information: As part of the prepublication editorial process, the review has been commented on by two peers from Cochrane Pregnancy and Childbirth (an editor and one referee who is external to the editorial team). The authors are grateful to Jim Thornton, Prof OBGYN at the University of Nottingham, UK, for his time and comments. As part of the Cochrane Diagnostic Test Accuracy Editorial Team (DTA-ET) the protocol was commented on by four peers (an editor, and three peer referees). This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Evidence Synthesis Programme, the NIHR, National Health Service (NHS) or the Department of Health and Social Care. Funding Information: Yousif Dawood receives funding from the AMC PhD scholarship for the length of four year (January 2018 to December 2021) for the conception of a microfocus computed tomography (micro-CT) based three-dimensional atlas of human fetal development. There is no conflict of interest. Funding Information: Harsha Shah receives funding from Samsung Medison South Korea to support travel costs for research in three-dimensional ultrasound. She received payment from NeuroLogica Corporation to present in a webinar on first trimester 3D ultrasound imaging. Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2021/7/21
Y1 - 2021/7/21
N2 - Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. The main objectives of this review are to assess the diagnostic accuracy of first- and second-trimester fetal anomaly screening in low-risk pregnant women, and to compare overall performance of single- and two-stage screening approaches with regards to the number of cases detected before birth, as well as the proportion of false positive diagnoses. Secondary objectives Our secondary objective is to identify potential sources of heterogeneity between studies by investigating the effect of clinical factors (i.e. prior testing, factors related to the conduct of the ultrasound examination, and healthcare setting of the study) and methodological factors (i.e. related to the study design, such as methods used for postnatal ascertainment of cases) on screening performance.
AB - Objectives: This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:. The main objectives of this review are to assess the diagnostic accuracy of first- and second-trimester fetal anomaly screening in low-risk pregnant women, and to compare overall performance of single- and two-stage screening approaches with regards to the number of cases detected before birth, as well as the proportion of false positive diagnoses. Secondary objectives Our secondary objective is to identify potential sources of heterogeneity between studies by investigating the effect of clinical factors (i.e. prior testing, factors related to the conduct of the ultrasound examination, and healthcare setting of the study) and methodological factors (i.e. related to the study design, such as methods used for postnatal ascertainment of cases) on screening performance.
UR - http://www.scopus.com/inward/record.url?scp=85111245803&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/14651858.CD014715
DO - https://doi.org/10.1002/14651858.CD014715
M3 - Article
SN - 1464-780X
VL - 2021
JO - Cochrane Library
JF - Cochrane Library
IS - 7
M1 - CD014715
ER -